Overdose deaths increased in pregnant and postpartum women from early 2018 to late 2021

Among those aged 35 to 44, overdose mortality more than tripled during this period, NIH study reports [] [View as webpage / Share]( [NIH/NIDA logo] NEWS [A pregnant young woman is sitting on the bed at home, tenderly holding her belly. ] Overdose deaths increased in pregnant and postpartum women from early 2018 to late 2021 Drug overdose deaths rose markedly between January to June 2018 and July to December 2021 among 10- to 44-year-old girls and women who were pregnant or pregnant within the previous 12 months, according to a new study by researchers at National Institute on Drug Abuse (NIDA) at the National Institutes of Health. Overdose mortality more than tripled among those aged 35 to 44 during the study period, from 4.9 deaths per 100,000 mothers aged 35 to 44 with a live birth in the 2018 period to 15.8 in the 2021 period. Over 60% of these pregnancy-associated overdose deaths occurred outside healthcare settings, though often in counties with available healthcare resources, such as emergency and obstetric care. Published today in JAMA Psychiatry, the findings suggest that, while treatment is available to pregnant women with substance use disorders, significant barriers – such as penalization, stigma, discrimination, and limited socioeconomic resources – may obstruct the path to care, the authors note. [View Press Release]( Stay Connected [facebook]([twitter]([linkedin]([youtube]( --------------------------------------------------------------- View topics of interest, update your subscriptions, modify your password or email address, alter frequency of bulletins, or stop subscriptions at any time on your [Subscriber Preferences Page](. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit [subscriberhelp.govdelivery.com](. This service is provided to you at no charge by [National Institute on Drug Abuse](. --------------------------------------------------------------- This email was sent to {EMAIL} using govDelivery Communications Cloud on behalf of National Institutes of Health: National Institute on Drug Abuse · 3WFN MSC 6024 · 16071 Industrial Dr ·Dock 11 · Gaithersburg, MD 20877 [GovDelivery logo](